Global Pharmatech, Inc.
GBLP · OTC
3/31/2025 | 12/31/2024 | 9/30/2024 | 6/30/2024 | |
|---|---|---|---|---|
| Market Cap | $100,498 | $61,795 | $138,324 | $138,324 |
| - Cash | $33 | $30 | $16 | $29 |
| + Debt | $90 | $80 | $90 | $80 |
| Enterprise Value | $100,555 | $61,845 | $138,399 | $138,376 |
| Revenue | $25 | $26 | $145 | $113 |
| % Growth | -4.7% | -82.1% | 27.5% | – |
| Gross Profit | $13 | -$5 | $20 | $5 |
| % Margin | 51.2% | -20.1% | 13.5% | 4.6% |
| EBITDA | $6 | -$17 | -$0 | -$32 |
| % Margin | 25.3% | -66.8% | -0.1% | -28.3% |
| Net Income | $4 | -$25 | -$0 | -$33 |
| % Margin | 18.2% | -95.3% | -0.3% | -28.9% |
| EPS Diluted | 0 | -0 | 0 | -0 |
| % Growth | 100% | – | 100% | – |
| Operating Cash Flow | -$58 | -$7 | $28 | $11 |
| Capital Expenditures | $58 | $7 | -$28 | -$11 |
| Free Cash Flow | $0 | $0 | $0 | $0 |